TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ELI LILLY & CO TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - ELI LILLY & CO Share Price
Certificat
DE000SU99249
| Market Closed - Boerse Frankfurt Warrants 20:42:03 07/06/2024 BST | ||
| 50.44 EUR | -1.73% |
|
| Current month | -6.33% | ||
| 1 month | -12.47% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 07/06/24 | 50.17 | -2.26% |
| 06/06/24 | 51.33 | -0.60% |
| 05/06/24 | 51.64 | -0.37% |
| 04/06/24 | 51.83 | -0.15% |
| 03/06/24 | 51.91 | -3.08% |
Real-time Boerse Frankfurt Warrants
Last update June 07, 2024 at 08:42 pm
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| WKN | SU9924 |
| ISIN | DE000SU99249 |
| Date issued | 05/03/2024 |
| Strike | 1,393 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 55.3 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 62.94 € |
|---|---|
| Lowest since issue | 50.17 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
850
USD
Average target price
853.8
USD
Spread / Average Target
+0.44%
- Stock Market
- Certificates
- Certificat
